CFO
AMED

CVA Family Office’s Amedisys AMED Stock Holding History

CVA Family Office’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-80
Closed -$13K – 946
2021
Q4 		$13K Buy
+80
New +$12.9K ﹤0.01% 596
2021
Q3 		– Sell
-10
Closed -$2K – 383
2021
Q2 		$2K Buy
+10
New +$2.62K ﹤0.01% 866

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CVA Family Office's AMED Position: Q1 2022 in Review

CVA Family Office sold out of Amedisys (AMED) in Q1 2022, closing a stake of 80 shares — an estimated $13K sold.

CVA Family Office first reported a position in AMED in Q2 2021 and held it in 2 quarters. The position peaked at $13K in Q4 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • CVA Family Office reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • CVA Family Office sold 80 Amedisys shares in Q1 2022, an estimated $13K.
  • CVA Family Office first reported a position in Amedisys in Q2 2021 and held it in 2 quarters.
  • CVA Family Office's Amedisys position peaked at $13K in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on CVA Family Office's 13F filing for Q1 2022, filed 22 Apr 2022.